UnitedHealth Group Incorporated

UnitedHealth Group fell as the company reported a 32.7% decline in EPS from a year ago, with net margins shrinking to 3.1%. Revenue grew 6.5%, but rising medical costs ate into profitability. The stock now trades at 25.6 times earnings, below its five-year average. UNH shares sit near the lower end of their 52-week range, about 32% below the January high of $461.62. The Alpha Score of 35.7 reflects weak momentum and middling value and quality scores; sentiment at 50 sits exactly neutral. Investors will watch next quarter's medical cost ratio for signs of stabilization in the commercial and Medicare Advantage segments.

UnitedHealth Group (UNH) traded lower Monday, with the stock sitting well off its 52-week high of $461.62 and near the lower half of its range. The stock carries a P/E of 25.63 against trailing EPS of $15.55, but the earnings picture has deteriorated sharply: EPS fell 32.7% year over year even as revenue grew 6.5%. Net margin compressed to 3.1%, a thin level for a company of this scale. The Alpha Score sits at 35.7, with value and quality sub-scores nearly identical at 35.2 and 35.9, while momentum is null. Sentiment reads 50, a neutral midpoint. The divergence between top-line growth and bottom-line collapse points to cost pressure or one-time charges, not a demand problem. Watch next week's managed-care utilization data and any update on the company's insurance segment, which will determine whether margin stabilizes or erodes further.

UnitedHealth Group (UNH) reported a 32.7% year-over-year drop in EPS to $15.55, while revenue grew 6.5%. Net margin compressed to 3.1%, a sharp retreat from prior-year levels. The stock sits near the lower end of its 52-week range at $255.97-$461.62, trading at 25.63 times trailing earnings. The Alpha Score of 35.7 reflects weak momentum and value (35.2) and quality (35.9) sub-scores, with sentiment at 50. The earnings decline outpaces the revenue slowdown, pointing to cost pressures in the insurance and care-delivery segments. Management didn't offer a revised outlook on the call, leaving investors to weigh whether the margin trough is in. Watch the next quarterly enrollment update and any commentary on medical cost trends, which will determine if the current valuation holds.

UnitedHealth Group shares trade near the lower end of their 52-week range after the company reported a 32.7% decline in EPS year-over-year, despite a 6.5% revenue increase. Net margin slipped to 3.1%. The stock's Alpha Score of 35.7 reflects weak momentum (null), value at 35.2, and quality at 35.9, while sentiment holds at 50. The P/E of 25.63 remains elevated relative to the earnings contraction. Investors will watch for margin recovery and guidance in the next quarterly report.

UnitedHealth shares trade near the middle of their 52-week range after EPS fell 32.7% year-over-year to $15.55, cutting net margin to 3.1%. Revenue grew 6.5% but that did not offset the profit decline. The P/E of 25.63 is elevated relative to the earnings base. Alpha Score sits at 35.7, with sentiment the highest sub-score at 50 and momentum effectively flat. The medical cost ratio will be the key metric when the company reports next quarter, as investors gauge whether margin pressure is stabilizing or worsening.